Li K, Yao J, Shi L, Sawada N, Chi Y, Yan Q, Matsue H, Kitamura M, Takeda M. Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells. J Biol Chem. 2011 Dec 2;286(48):41552-41562
Hanawa F, Inozume T, Harada K, Kawamura T, Shibagaki N, Shimada S. A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy. Case Rep Dermatol. 2011 Sep;3(3):223-227
Shibagaki N, Okamoto T, Mitsui H, Inozume T, Kanzaki M, Shimada S. Novel immunotherapeutic approaches to skin cancer treatments using protein transduction technology. J Dermatol Sci. 2011 Mar;61(3):153-161
Hanada K, Wang QJ, Inozume T, Yang JC. Molecular identification of an MHC-independent ligand recognized by a human {alpha}/{beta} T-cell receptor. Blood. 2011 May 5;117(18):4816-4825
Wang QJ, Hanada K, Feldman SA, Zhao Y, Inozume T, Yang JC.Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma. J Immunol Methods. 2011 Mar 7;366(1-2):43-51
Kawamura T, Ogawa Y, Shimozato O, Ando T, Nakao A, Kobata T, Okumura K, Yagita H, Shimada S. CD70 is selectively expressed on Th1 but not on Th2 cells and is required for Th1-type immune responses. J Invest Dermatol. 2011 Jun;131(6):1252-1261
Suzuki K, Murphy SH, Xia Y, Yokota M, Nakagomi D, Liu F, Verma IM, Nakajima H. Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activation. PLoS One. 2011;6(9):e25412.
Iida K, Suzuki K, Yokota M, Nakagomi D, Wakashin H, Iwata A, Kawashima H, Takatori H, Nakajima H. STAT4 is required for IFN-β-induced MCP-1 mRNA expression in murine mast cells. Int Arch Allergy Immunol. 2011;155 Suppl 1:71-6.
Koga S, Ikeda K, Nakagomi D, Mori M, Kuwabara S, Nakajima H. A patient with neuromyelitis optica with positive anti-Ro (SS-A) antibody presenting with intractable hiccup and nausea. Mod Rheumatol. 2011 ;21(5):561-2.
Moussai D, Mitsui H, Pettersen JS, Pierson KC, Shah KR, Suarez-Farinas M, Cardinale IR, Bluth MJ, Krueger JG, Carucci JA. The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. J Invest Dermatol. 2011 Jan;131(1):229-236
Belkin DA, Mitsui H, Felsen D, and Carucci JA. VEGF-C-producing macrophages in cutaneous squamous cell carcinoma. Expert Rev Dermatol. 2011; 6, 643-651